skip navigation


Part A—Drugs and Devices

  • § 351. Adulterated drugs and devices
  • § 352. Misbranded drugs and devices
  • § 353. Exemptions and consideration for certain drugs, devices, and biological products
  • § 353a. Pharmacy compounding
  • § 354. Veterinary feed directive drugs
  • § 355. New drugs
  • § 355a. Pediatric studies of drugs
  • § 355b. Adverse-event reporting
  • § 355c. Research into pediatric uses for drugs and biological products
  • § 356. Fast track products
  • § 356-1. Accelerated approval of priority countermeasures
  • § 356a. Manufacturing changes
  • § 356b. Reports of postmarketing studies
  • § 356c. Discontinuance of life saving product
  • § 357. Repealed.]
  • § 358. Authority to designate official names
  • § 359. Nonapplicability of subchapter to cosmetics
  • § 360. Registration of producers of drugs or devices
  • § 360a. Repealed.]
  • § 360b. New animal drugs
  • § 360c. Classification of devices intended for human use
  • § 360d. Performance standards
  • § 360e. Premarket approval
  • § 360f. Banned devices
  • § 360g. Judicial review
  • § 360h. Notification and other remedies
  • § 360i. Records and reports on devices
  • § 360j. General provisions respecting control of devices intended for human use
  • § 360k. State and local requirements respecting devices
  • § 360l. Postmarket surveillance
  • § 360m. Accredited persons

  • LII has no control over and does not endorse any external Internet site that contains links to or references LII.